Two more drug-making giants, Abbvie and Genentech, will start selling popular medications on the White House's discounted ...

Drug companies AbbVie and Genentech will start selling medications at lower prices through the White House’s "TrumpRx" website.

Humira and Botox maker AbbVie is suing the Trump administration to get a clearer definition of who counts as an eligible ...

AbbVie is launching Humira on the TrumpRx platform with an 86% discount under a pricing agreement with the White House. The ...

Humira will be available on TrumpRx at an 86% discount, according to media reports, as part of AbbVie's deal with the White House to avoid tariffs. The news comes less than a week after the president ...

It’s been a little over two months since President Donald Trump’s direct-to-consumer pharmaceutical site, TrumpRx, launched, ...

The Food and Drug Administration has granted an expanded interchangeable designation for Celltrion’s Yuflyma (adalimumab-aaty), now including prefilled syringe (40mg) and autoinjectors (40mg and 80mg) ...

Humira (adalimumab) is a long-term maintenance medication used to manage chronic conditions like Crohn’s disease and rheumatoid arthritis. For many people, this drug is not a short-term fix but a ...

Researchers from University College London have discovered that the widely used antiinflammatory drug HUMIRA doesn't just work by inhibiting its target protein, TNF, but by enhancing a particular ...